Related Experiment Videos

[Treatment of arrhythmia by intracardiac electrocoagulation]

Schweizerische Medizinische Wochenschrift
|January 10, 1987
PubMed

Insights

Catheter ablation effectively treats refractory supraventricular arrhythmias by targeting pathways like the His bundle. While successful for many, His bundle ablation often requires pacemakers, and outcomes for ventricular arrhythmias require further study.

Area of Science:

  • Electrophysiology
  • Cardiology
  • Medical Devices

Context:

  • Refractory arrhythmias pose significant clinical challenges.
  • Catheter ablation emerged as a novel therapeutic approach.
  • Limited data existed on its efficacy and safety for diverse arrhythmia types.

Purpose:

  • To evaluate the effectiveness and safety of catheter ablation for refractory arrhythmias.
  • To assess outcomes based on the specific ablated cardiac pathway.
  • To determine the feasibility of catheter ablation for supraventricular and ventricular arrhythmias.

Summary:

  • Twelve patients underwent catheter ablation for refractory arrhythmias, targeting the His bundle (8 patients), accessory pathways (3), or ventricular circuits (1).
  • His bundle ablation resulted in heart block in most cases, often necessitating pacemakers. Accessory pathway ablation showed mixed results.
  • One patient with ventricular tachycardia remained free of recurrence. Mean follow-up was 12 months with minimal complications.

Impact:

  • Catheter ablation is a promising treatment for refractory supraventricular tachyarrhythmias.
  • Further research is needed to establish its role in managing ventricular arrhythmias.
  • The procedure demonstrates a favorable safety profile with potential for significant patient benefit.

Related Concept Videos